Cargando…
Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study
BACKGROUND: Relapsing-remitting multiple sclerosis (RRMM) is a chronic, progressive, inflammatory and immune-mediated disease that affects the central nervous system and is characterized by episodes of neurological dysfunction followed by a period of remission. The pharmacological strategy aims to d...
Autores principales: | Souza, Kathiaja Miranda, Diniz, Isabela Maia, de Lemos, Lívia Lovato Pires, Junior, Nélio Gomes Ribeiro, Zuppo, Isabella de Figueiredo, Teodoro, Juliana Alvares, Acurcio, Francisco de Assis, Atallah, Álvaro Nagib, Júnior, Augusto Afonso Guerra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467258/ https://www.ncbi.nlm.nih.gov/pubmed/32877451 http://dx.doi.org/10.1371/journal.pone.0238476 |
Ejemplares similares
-
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
por: Lemos, Livia Lovato Pires de, et al.
Publicado: (2017) -
The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil
por: Maia Diniz, Isabela, et al.
Publicado: (2018) -
Survival Analysis of COPD Patients in a 13-Year Nationwide Cohort Study of the Brazilian National Health System
por: Gargano, Ludmila Peres, et al.
Publicado: (2022) -
Who should pay for the continuity of post-trial health care treatments?
por: Iunes, Roberto, et al.
Publicado: (2019) -
Confidentiality agreements: a challenge in market regulation
por: Iunes, Roberto F., et al.
Publicado: (2019)